Endoscopic Duodenal Mucosal Resurfacing for the Treatment of Type 2 Diabetes: 6-Month Interim Analysis From the First-in-Human Proof-of-Concept Study.

scientific article

Endoscopic Duodenal Mucosal Resurfacing for the Treatment of Type 2 Diabetes: 6-Month Interim Analysis From the First-in-Human Proof-of-Concept Study. is …
instance of (P31):
scholarly articleQ13442814

External links are
P356DOI10.2337/DC16-0383
P698PubMed publication ID27519448

P50authorAlan D. CherringtonQ60573078
Harith RajagopalanQ88116508
P2093author name stringLee M Kaplan
Christopher C Thompson
Francesco Rubino
Geltrude Mingrone
Pablo Becerra
Patricia Rodriguez
Manoel P Galvao Neto
Leonardo Rodriguez
Jay Caplan
Paulina Vignolo
P433issue12
P407language of work or nameEnglishQ1860
P921main subjecttype 2 diabetesQ3025883
P304page(s)2254-2261
P577publication date2016-08-12
P1433published inDiabetes CareQ5270111
P1476titleEndoscopic Duodenal Mucosal Resurfacing for the Treatment of Type 2 Diabetes: 6-Month Interim Analysis From the First-in-Human Proof-of-Concept Study
P478volume39

Reverse relations

cites work (P2860)
Q48317296A Prospective Single-Arm Trial of Modified Long Biliopancreatic and Short Alimentary Limbs Roux-En-Y Gastric Bypass in Type 2 Diabetes Patients with Mild Obesity.
Q46084030ASGE EndoVators Summit: Defining the Role and Value of Endoscopic Therapies in Obesity Management
Q61905346ASGE EndoVators Summit: Defining the Role and Value of Endoscopic Therapies in Obesity Management
Q61905355ASGE EndoVators Summit: defining the role and value of endoscopic therapies in obesity management
Q47256071Ablation of the Duodenal Mucosa as a Strategy for Glycemic Control in Type 2 Diabetes: Role of Nutrient Signaling or Simple Weight Loss
Q90465244Current and Future Endoscopic Weight Loss Solutions
Q52581465Devices and Endoscopic Bariatric Therapies for Obesity.
Q50075045Diabetes and the Small Intestine
Q55071381Duodenal L cell density correlates with features of metabolic syndrome and plasma metabolites.
Q41999658Endoluminal weight loss and metabolic therapies: current and future techniques
Q33811372Endoscopic Accessories Used for More Advanced Endoluminal Therapeutic Procedures
Q88673275Endoscopic Interventions in the Treatment of Obesity and Diabetes
Q49899718Endoscopic Medical Devices for Primary Obesity Treatment in Patients With Diabetes
Q47891302Endoscopic Treatments for Obesity.
Q92090714Endoscopic duodenal mucosal resurfacing for the treatment of type 2 diabetes mellitus: one year results from the first international, open-label, prospective, multicentre study
Q89624077Endoscopic duodenal mucosal resurfacing improves glycaemic and hepatic indices in type 2 diabetes: 6-month multicentre results
Q92068499Endoscopic intragastric balloon: a gimmick or a viable option for obesity?
Q64067771Histologic assessment of the intestinal wall following duodenal mucosal resurfacing (DMR): a new procedure for the treatment of insulin-resistant metabolic disease
Q88312453Latest Developments and Future Perspectives in the Field Of Obesity
Q39429642Medical devices for the treatment of obesity
Q99610102Overview of bariatric and metabolic endoscopy interventions
Q37633943Recent Clinical Results of Endoscopic Bariatric Therapies as an Obesity Intervention
Q37633938Recent Trends in Endoscopic Bariatric Therapies
Q92544525Simulation of gastric bypass effects on glucose metabolism and non-alcoholic fatty liver disease with the Sleeveballoon device
Q59127264Small Bowel Endoscopic Bariatric Therapies
Q53438835The Science of Obesity Management: An Endocrine Society Scientific Statement.
Q89624069The changing face of hepatology
Q94093775UEG Week 2018 Poster Presentations
Q57146078Updated panel report: best practices for the surgical treatment of obesity